Siddhant Khandekar
ICICI Securities

Analyst Rank Summary

SECTOR RANK

Healthcare
13

STOCK RANK

Cadila Healthcare
1
Glenmark Pharmaceuticals
1

OVERALL RANK

118

Analyst Performance

RETURNS
ACCURACY
SHARPE RATIO

Overall

37%

Overall

21%

Overall

48%

Analyst Current and Past Recommendations

Total 112 Recos

HIKAL

Hikal

3%

15%

Buy

160.40

Reco given

5d ago

164.75

16-Oct 4:00 PM

190

Target

12m out

SUVEN

Suven Life Sciences

2%

22%

Buy

253.75

Reco given

7d ago

257.95

16-Oct 4:00 PM

315

Target

12m out

AUROPHARMA

Aurobindo Pharma

23%

22%

Buy

610.85

Reco given

1m ago

752.75

15-Oct 4:00 PM

915

Target

11m out

SYNGENE

SYNGENE INTERNATIONAL LIMITED

-4%

25%

Buy

615.60

Reco given

6m ago

589.10

16-Oct 4:00 PM

735

Target

3m out

HESTERBIO

HESTER BIOSCIENCES LIMITED

-28%

59%

Buy

1650.70

Reco given

9m ago

1188.95

16-Oct 4:00 PM

1890

Target

3m out

NH

NARAYANA HRUDAYALAYA LTD.

-25%

61%

Buy

298.75

Reco given

10m ago

223.40

16-Oct 4:00 PM

360

Target

2m out

Loading...
Loading...
Loading...
 
Unregistered Users
Registered Users (FREE)

Stock Recommendations

   
Recommendations by Top Ranked Analysts close ok
Recommendations by all other Analysts ok ok
Extreme Upside Recommendations by Top Ranked Analysts close ok
Extreme Downside Recommendations by Top Ranked Analysts close ok

Analysts Ranking

   
Top Ranked Analysts close ok
Top Ranked Analysts by Sector close ok
Top Ranked Analysts by Stock close ok

Favourites/Watchlists

close ok
Sign Up

Email:*

Name:*

Password:*

Confirm Password:*

Gender:

Age:

I invest in:
Stocks Mutual Funds
Fixed Deposits Gold
Commodities
I learnt about MilkorWater from:
Friends Colleague
Media Internet Other
Sign-up for Free
How do I choose my investment?
Tips from Friends
Advice from Experts
How do I trust the stock tips?
Smart and Unbiased Stock Ideas from MilkorWater
Filtering Top Rated Stock Ideas from thousands of Analyst Recommendations
Free Registration

Feedback
Name
Role
Email
Message
Contact me for further clarification
  Submit    Cancel